Elite in COVID-19

Dr. Robert Gottlieb

Advanced Heart Failure and Transplant Cardiology
Baylor Scott & White Health
Baylor Scott & White Advanced Heart Failure Clinic Dallas
3410 Worth St, Ste 250, 
Dallas, TX 
Clinical Trials:Currently Recruiting for 1 Trial
Elite in COVID-19
Baylor Scott & White Health
Baylor Scott & White Advanced Heart Failure Clinic Dallas
3410 Worth St, Ste 250, 
Dallas, TX 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Robert Gottlieb is an Advanced Heart Failure and Transplant Cardiologist in Dallas, Texas. Dr. Gottlieb is rated as an Elite provider by MediFind in the treatment of COVID-19. His top areas of expertise are COVID-19, Pulmonary Hypertension, Heart Failure, Heart Transplant, and Endoscopy.

His clinical research consists of co-authoring 79 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 54 articles and participated in 4 clinical trials in the study of COVID-19.

Residency
Internal Medicine, University of Iowa Hospitals and Clinics Education: University of Iowa Hospitals and Clinics
Specialties
Advanced Heart Failure and Transplant Cardiology
Licenses
Internal Medicine in NC
Board Certifications
American Board Of Cardiovascular Medicine
Fellowships
Cardiovascular Disease, University of Iowa Hospitals and Clinics
Advanced Heart Failure & Transplant Cardiology, University of Iowa Hospitals and Clinics
Hospital Affiliations
Baylor Scott & White Heart & Vascular Hospital - Dallas
Baylor University Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Baylor Scott & White Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
FirstCare
  • HMO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Independent Health
  • EPO
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Scott and White Health
  • HMO
  • POS
Superior Health Plan
  • MANAGED MEDICAID PLAN
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

Baylor Scott & White Advanced Heart Failure Clinic Dallas
3410 Worth St, Ste 250, Dallas, TX 75246
Call: 972-449-0540

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
Transplant of Redeemed Organs by Judicious Administration of New Direct-Acting Antivirals for Hepatitis-C Heart Recipients
Enrollment Status: Recruiting
Publish Date: January 22, 2026
Intervention Type: Drug
Study Drug: Epclusa
Study Phase: Phase 2
Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study
Antiplatelet Removal and HemocompatIbility EventS With the HeartMate 3 Pump IDE Study
Enrollment Status: Completed
Publish Date: March 27, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
A Randomized, Double-blind, Placebo-Controlled, Phase 2/3 Study to Evaluate the Efficacy and Safety of LY3819253 and LY3832479 in Participants With Mild to Moderate COVID-19 Illness
Enrollment Status: Completed
Publish Date: April 11, 2024
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab
Study Phase: Phase 2/Phase 3
A Phase 3, Multinational, Randomized, Placebo-controlled Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation (REALM-DCM)
A Phase 3, Multinational, Randomized, Placebo-controlled Study of ARRY-371797 (PF-07265803) in Patients With Symptomatic Dilated Cardiomyopathy Due to a Lamin A/C Gene Mutation (REALM-DCM)
Enrollment Status: Terminated
Publish Date: January 09, 2024
Intervention Type: Other, Drug
Study Drug: ARRY-371797 (PF-07265803)
Study Phase: Phase 3
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy and Safety of Mono and Combination Therapy With Monoclonal Antibodies in Participants With Mild to Moderate COVID-19 Illness (BLAZE-4)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drugs: Bamlanivimab, Etesevimab, LY3853113 Anti-COVID-19 Antibody, VIR-7831 Anti-COVID-19 Antibody
Study Phase: Phase 2
Mesenchymal Stromal Cells for the Treatment of Moderate to Severe COVID-19 Acute Respiratory Distress Syndrome
Mesenchymal Stromal Cells for the Treatment of Moderate to Severe COVID-19 Acute Respiratory Distress Syndrome
Enrollment Status: Terminated
Publish Date: April 25, 2022
Intervention Type: Biological, Drug
Study Drug: Remestemcel-L
Study Phase: Phase 3
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
A Multi-Center, Adaptive, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy and Safety of Gimsilumab in Subjects With Lung Injury or Acute Respiratory Distress Syndrome Secondary to COVID-19 (BREATHE)
Enrollment Status: Completed
Publish Date: December 14, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

2 Total Publications

Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Patisiran Treatment in Patients with Transthyretin Cardiac Amyloidosis.
Journal: The New England journal of medicine
Published: October 27, 2023
View All 2 Publications
Similar Doctors
Maryjane A. Farr
Experienced in COVID-19
Dr. Maryjane A. Farr
Advanced Heart Failure and Transplant Cardiology | Cardiology
Experienced in COVID-19
Dr. Maryjane A. Farr
Advanced Heart Failure and Transplant Cardiology | Cardiology

University Of Texas Southwestern Medical Center At Dallas

5939 Harry Hines Blvd, 
Dallas, TX 
 (4.2 miles away)
214-645-0624
Languages Spoken:
English
See accepted insurances

Maryjane Farr is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Dallas, Texas. Dr. Farr is rated as a Distinguished provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Heart Failure, Cardiogenic Shock, Cardiomyopathy, Pulmonary Edema, and Heart Transplant.

Experienced in COVID-19
Dr. Nicholas S. Hendren
Advanced Heart Failure and Transplant Cardiology | Cardiology
Experienced in COVID-19
Dr. Nicholas S. Hendren
Advanced Heart Failure and Transplant Cardiology | Cardiology

University Of Texas Southwestern Medical Center At Dallas

600 S Main St, 
Fort Worth, TX 
 (31.9 miles away)
817-882-2400
Languages Spoken:
English
See accepted insurances

Nicholas Hendren is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Fort Worth, Texas. Dr. Hendren is rated as a Distinguished provider by MediFind in the treatment of COVID-19. His top areas of expertise are Heart Failure, Cardiogenic Shock, Myocarditis, Heart Transplant, and Heart Bypass Surgery.

Experienced in COVID-19
Dr. Aditi Nayak
Advanced Heart Failure and Transplant Cardiology | Cardiology
Experienced in COVID-19
Dr. Aditi Nayak
Advanced Heart Failure and Transplant Cardiology | Cardiology

Healthtexas Provider Network

4001 Worth St, 
Dallas, TX 
 (0.3 miles away)
Languages Spoken:
English
See accepted insurances

Aditi Nayak is an Advanced Heart Failure and Transplant Cardiologist and a Cardiologist in Dallas, Texas. Dr. Nayak is rated as an Advanced provider by MediFind in the treatment of COVID-19. Her top areas of expertise are Heart Failure, Peripartum Cardiomyopathy, Tricuspid Regurgitation, COVID-19, and Heart Transplant.

VIEW MORE COVID-19 DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gottlieb's expertise for a condition
ConditionClose
  • Elite
  • COVID-19
    Dr. Gottlieb is
    Elite
    . Learn about COVID-19.
    See more COVID-19 experts
    • Advanced
    • Cardiomyopathy
      Dr. Gottlieb is
      Advanced
      . Learn about Cardiomyopathy.
      See more Cardiomyopathy experts
    • Familial Transthyretin Amyloidosis
      Dr. Gottlieb is
      Advanced
      . Learn about Familial Transthyretin Amyloidosis.
      See more Familial Transthyretin Amyloidosis experts
    • Heart Failure
      Dr. Gottlieb is
      Advanced
      . Learn about Heart Failure.
      See more Heart Failure experts
    • Heart Transplant
      Dr. Gottlieb is
      Advanced
      . Learn about Heart Transplant.
      See more Heart Transplant experts
    • Pulmonary Edema
      Dr. Gottlieb is
      Advanced
      . Learn about Pulmonary Edema.
      See more Pulmonary Edema experts
    • Pulmonary Hypertension
      Dr. Gottlieb is
      Advanced
      . Learn about Pulmonary Hypertension.
      See more Pulmonary Hypertension experts
    • Experienced
    • Arrhythmias
      Dr. Gottlieb is
      Experienced
      . Learn about Arrhythmias.
      See more Arrhythmias experts
    • Arrhythmogenic Right Ventricular Cardiomyopathy
      Dr. Gottlieb is
      Experienced
      . Learn about Arrhythmogenic Right Ventricular Cardiomyopathy.
      See more Arrhythmogenic Right Ventricular Cardiomyopathy experts
    • Bidirectional Tachycardia
      Dr. Gottlieb is
      Experienced
      . Learn about Bidirectional Tachycardia.
      See more Bidirectional Tachycardia experts
    • Cardiac Amyloidosis
      Dr. Gottlieb is
      Experienced
      . Learn about Cardiac Amyloidosis.
      See more Cardiac Amyloidosis experts
    • Cardiogenic Shock
      Dr. Gottlieb is
      Experienced
      . Learn about Cardiogenic Shock.
      See more Cardiogenic Shock experts
    • Catecholaminergic Polymorphic Ventricular Tachycardia
      Dr. Gottlieb is
      Experienced
      . Learn about Catecholaminergic Polymorphic Ventricular Tachycardia.
      See more Catecholaminergic Polymorphic Ventricular Tachycardia experts
    View All 23 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile
    For Patients
    • Our Story
    • How MediFind Works
    • Conditions A-Z
    • Doctor Directory
    • Symptoms Directory
    • Procedures Directory
    • Treatment Directory
    • Drug Directory
    • Infusion Center Finder
    • FAQ
    • Contact Us
    For Providers and Practices
    • Claim Your Profile
    • Newsroom
    Business Solutions
    • Provider
    • Network Solutions
    Additional Resources
    • Consumer Health Data Privacy Policy
    • Privacy Policy
    • Terms of Use
    • Advertising Policy
    • Content Policy
    Subscribe to our newsletter

    Sign up to stay informed about MediFind and get wellness sent your way.

    Close

      By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

      Bullet PinMediFind
      Follow us on
      This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
      © 2026 All Rights Reserved

      Request an Appointment

      If you are experiencing a medical emergency, call 9-1-1.

      MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

      Patient Details

      This information is for the patient who will be seen at the appointment.

        Close

        Returning patient? Use your address on file with the provider.

        Insurance Details

        Please provide information of the primary insurance holder as the practice may require this information to schedule.

        Insurance Provider *
        Insurance ProviderClose

        Appointments Details

        Let’s get more information about your appointment.

                0 / 1000
                0 / 1000
                By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.